Pfizer-BioNTech COVID-19 Vaccine Remains Highly Effective After 6 Months, Trial Data Show
WASHINGTON, April 2 – The ongoing phase three clinical trial of Pfizer-BioNTech’s COVID-19 vaccine showed its protection remains high for up to six months after the second dose, the two…